Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/05/1992 | US5110603 Bathing preparation for colloidal material |
05/05/1992 | US5110602 Solution or suspension in middle chain glyceride to inhibit degradation by digestive enzymes |
05/05/1992 | US5110600 Method of treating viral infections with amino acid analogs |
05/05/1992 | US5110599 Accuracy, uniformity |
05/05/1992 | US5110583 Peroxy acids composition for oral treatment |
05/05/1992 | CA1300313C2 Amino acid derivatives |
05/05/1992 | CA1300170C Process for intermediates to leukotriene antagonists |
05/05/1992 | CA1300169C Process for intermediates to leukotriene antagonists |
05/05/1992 | CA1300162C2 Benzamide, preparation process and therapeutic use |
05/05/1992 | CA1300161C Carboxamido dihydrobenzofuran and chroman derivatives, their preparation process and their use as neuroleptics |
05/05/1992 | CA1300157C Dihydropyridine compounds having unique pharmacological effects, and the process for producing them |
05/05/1992 | CA1300154C N-substituted piperid-4-yl benzamide compounds and 1-substituted-4-amino-piperidine compounds |
05/05/1992 | CA1300153C 2-pyridylacetic acid derivative, preparation process thereof and pharmaceutical composition containing the same |
05/05/1992 | CA1300152C Diacylderivatives of glycerylphosphorylcholine having therapeutical activity, a process for their preparation and related pharmaceutical compositions |
05/05/1992 | CA1300151C 1,3-dihydro-6-¬1-cyano-1-isopropyl-n-phenethyl-n-methyl- aminoalkyl|-7-hydroxy-furo-(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300150C 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300149C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo-(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300148C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300146C 12b-substituted 1-hydroxymethyl-octahydroindolo¬2,3-a|- quinolizine derivatives, process for the preparation and pharmaceutical compositions containing them |
05/05/1992 | CA1300145C Taurine-type compounds |
05/05/1992 | CA1300139C Piperazinyl-heterocyclic compounds |
05/05/1992 | CA1300138C Oxabicycloheptane derivatives |
05/05/1992 | CA1300135C Substituted quinoxalines |
05/05/1992 | CA1300133C Benzimidazolesulfonamides and imidazopyridinesulfonamides; process for preparing the same and their use as therapeutic agents |
05/05/1992 | CA1300131C Antibiotics retinoid esters, their preparation process and pharmaceutical and cosmetical compositions containing them |
05/05/1992 | CA1300125C Cephalosporin derivatives |
05/05/1992 | CA1300024C Agent having renal function-improving effect and diuretic effect |
05/05/1992 | CA1300021C Transdermal therapeutic systems for active ingredient combinations |
05/05/1992 | CA1300020C Method for treating male sexual dysfunction |
05/05/1992 | CA1300019C Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
05/05/1992 | CA1300018C Antigestagens for shifting the endometrial maturation |
05/05/1992 | CA1300017C Composition for preventing osteoporosis |
05/05/1992 | CA1300015C Compositions comprising 1-substituted azacycloalkanes |
05/03/1992 | WO1992007558A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
05/03/1992 | WO1992007557A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
05/03/1992 | CA2072889A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
05/03/1992 | CA2072884A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
05/03/1992 | CA2054648A1 1-(2-arylethyl)-pyrrolidines |
05/02/1992 | WO1992007867A1 Polysubstituted benzimidazoles as antiviral agents |
05/02/1992 | WO1992007866A1 Anthracycline analogues bearing latent alkylating substituents |
05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
05/02/1992 | CA2100098A1 Polysubstituted benzimidazoles as antiviral agents |
05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
05/02/1992 | CA2054653A1 Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use therefor |
05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
05/02/1992 | CA2054526A1 Controlled release formulations |
05/02/1992 | CA2054430A1 3-oxy-substituted isoxazolines, process for their preparation and their use for combating endoparasites |
05/01/1992 | WO1992007856A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES |
05/01/1992 | WO1992007853A1 Certain imidazoquinoxalines; a new class of gaba brain receptor ligands |
05/01/1992 | WO1992007851A1 PROCESS FOR THE PREPARATION OF 1β-ETHYL-1α-(HYDROXYMETHYL)-1,2,3,4,6,7,12,12bα-OCTAHYDRO-INDOLO[2,3-a]QUINOLIZINE AND NOVEL INTERMEDIATES |
05/01/1992 | WO1992007850A1 Novel compounds |
05/01/1992 | WO1992007839A1 Thiazolidinedione derivatives |
05/01/1992 | WO1992007561A1 Antiphlogistic and analgesic gel preparation |
05/01/1992 | CA2095219A1 Substituted indolizino[1,2-b]quinolinones |
05/01/1992 | CA2095147A1 Compounds |
05/01/1992 | CA2095146A1 Thiazolidinedione derivatives |
05/01/1992 | CA2071878A1 Process for the preparation of 1.alpha.-ethyl-1 -(hydroxymethyl)-1,2,3,4,6,7,12,12ba-octahydro-indolo¬2,3- a|quinolizine and novel intermediates |
05/01/1992 | CA2054594A1 Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives |
05/01/1992 | CA2054544A1 Process for the preparation of piperazine derivatives |
05/01/1992 | CA2054475A1 Composition with antierythemal activity and cosmetic use thereof |
05/01/1992 | CA2054465A1 Thienoimidazole derivatives, their production and use |
05/01/1992 | CA2054134A1 Method and composition for the protection of a metabolic recovery of ischemic cardiac tissue |
05/01/1992 | CA2052246A1 Lithium treatment |
04/30/1992 | WO1992007590A1 Transdermal contraceptive formulations, methods and devices |
04/30/1992 | WO1992007073A1 Osteogenic peptides |
04/30/1992 | WO1992007065A1 Modified ribozymes |
04/30/1992 | WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
04/30/1992 | WO1992006978A1 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
04/30/1992 | WO1992006975A1 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
04/30/1992 | WO1992006974A1 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
04/30/1992 | WO1992006973A1 Indole derivatives |
04/30/1992 | WO1992006967A1 Therapeutically useful 2-aminotetralin derivatives |
04/30/1992 | WO1992006960A1 Piperazine derivatives |
04/30/1992 | WO1992006957A1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
04/30/1992 | WO1992006948A1 Bi-aromatic compounds and their use in human and veterinary medecine and in cosmetic preparations |
04/30/1992 | WO1992006713A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies |
04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
04/30/1992 | WO1992006700A1 Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus |
04/30/1992 | WO1992006695A1 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
04/30/1992 | WO1992006692A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections |
04/30/1992 | WO1992006690A1 Treatment of non-inflammatory and non-infectious bowel disorders |
04/30/1992 | WO1992006688A1 New medical use for a certain indole derivative and pharmaceutical composition containing it |
04/30/1992 | WO1992006685A1 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
04/30/1992 | WO1992006684A1 A new use of enprostil |
04/30/1992 | WO1992006683A1 Aryl and heteroaryl compounds having anti-retrovirus activity |
04/30/1992 | WO1992006682A1 Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal |
04/30/1992 | WO1992006679A1 A method for drug formulation and a pharmaceutical composition |
04/30/1992 | WO1992003412A3 Benzamide derivatives |
04/30/1992 | WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs |
04/30/1992 | WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes |
04/30/1992 | DE4034090A1 Treating disease caused by normal or modified lipoprotein(s) |
04/30/1992 | CA2094139A1 Aryl and heteroaryl compounds having anti-retrovirus activity |
04/30/1992 | CA2093527A1 New medical use for a certain indole derivative and pharmaceutical composition containing it |
04/30/1992 | CA2091883A1 Transdermal contraceptive formulations, methods and devices |
04/30/1992 | CA2071940A1 Piperazine derivatives |
04/30/1992 | CA2054347A1 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them |
04/29/1992 | EP0483105A1 Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers |
04/29/1992 | EP0483077A2 A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas. |
04/29/1992 | EP0483070A2 Nutritionally complete feeding composition containing hydrolysed soluble fiber |